Document is current
Any future updates will be listed below
-
Authors
Chen, Joann J.
Mermin, Sam A.
Duffy, Lucie A.
Wong, Samantha A.
Layfield, Savannah D.
Rodriguez-Villa, Fernando
Gelda, Steven E.
Gelwan, Eliot M.
Eisen, Jane
Ressler, Kerry J.
Choi-Kain, Lois W.
Yip, Agustin G.
- License Information
-
More Information
Article History
Received: 11 November 2024
Accepted: 2 May 2025
First Online: 5 May 2025
Declarations
:
: Data were collected as part of McLean Hospital’s Clinical Measurements Initiative (CMI) data collection process. The methods used for data collection and analysis data adhered to the Declaration of Helsinki. Specifically, this study and retrospective analysis of these data were classified as consent- exempt and approved by the Mass General Brigham Institutional Review Board (IRB).
: Not applicable. This study and retrospective analysis of these data were classified as consent- exempt and approved by the Mass General Brigham Institutional Review Board.
: Dr. Ressler reports having performed scientific consultation for Bioxcel, Bionomics, Acer, and Jazz Pharmaceuticals. He serves on Scientific Advisory Boards for Sage Therapeutics, Boehringer Ingelheim, and the Brain Research Foundation, and he has received sponsored research support from Brainsway and Alto Neuroscience. None of these roles are related to the current publication. Dr. Choi-Kain receives royalties from American Psychiatric Association Publishing for royalites on Good Psychiatric Management books, as well as consulting fees from Tetricus. No other authors have disclosures to report.
